NCT01507922 - Comparative Efficacy and Safety of Fenoverine | Biotech Hunter

Enrollment

186

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

June 30, 2013

Conditions

Irritable Bowel Syndrome

Interventions

DRUG

Fenoverine

Fenoverine 100mg three times a day for 8 weeks

DRUG

Timebutine

Timebutine maleate 150mg three times a day for 8 weeks

Trial Locations (7)

Korea University Ansan Hospital, Ansan

Hallym University Sacred Heart Hospital, Anyang

Kangwon National University Hospital, Chuncheon

Gachon University Gil Hospital, Incheon

Inje University Seoul Paik Hospital, Seoul

Korea University Anam Hospital, Seoul

Korea University Guro Hospital, Seoul